Symptoms Indicating Candidacy for BVNA
Patients are candidates for basivertebral nerve ablation when they present with chronic axial (midline) low back pain lasting ≥6 months that worsens with sitting, forward flexion, bending, and lifting, improves with standing or walking, and demonstrates Modic type 1 or type 2 endplate changes on MRI after failing conservative management. 1, 2
Core Clinical Features
Pain Characteristics
- Axial (midline) low back pain - not radicular or leg-dominant pain 2
- Mechanical pattern: worse with sitting, forward flexion, bending, lifting, and driving 3
- Relief pattern: improves with standing, walking, or lying down 3
- Duration: minimum 6 months of persistent symptoms 1, 4
Essential Imaging Findings
- Modic type 1 changes (bone marrow edema on MRI - hyperintense on T2, hypointense on T1) OR
- Modic type 2 changes (fatty marrow replacement - hyperintense on both T1 and T2) 5, 1, 2
- Changes must be present at the vertebral endplates corresponding to the pain location 3
Treatment Failure Requirements
Patients must have failed conservative management before BVNA consideration 1. This includes:
- Nonsteroidal anti-inflammatory drugs
- Physical therapy
- Activity modification
- Other interventional procedures (epidural injections, facet interventions, medial branch blocks) 3
The 2025 BMJ guideline 6 strongly recommends against epidural injections and radiofrequency ablation for chronic axial spine pain, which reinforces that patients failing these traditional interventions may benefit from BVNA as a distinct treatment targeting a different pain generator.
Expanding Indications
Recent evidence 5, 7, 3 demonstrates BVNA efficacy beyond original trial criteria:
- Post-fusion patients with persistent vertebrogenic pain at adjacent or fused levels 3
- Advanced osteopenia (T-score -2.2) without fracture 7
- Multilevel Modic changes 4
Critical Exclusion Criteria
- Active vertebral compression fracture - this is the key distinction from your clinical scenario
- Neurologic deficits requiring surgical decompression
- Active spinal infection
- Uncorrectable coagulopathy 1
Important Clinical Distinction
BVNA addresses vertebrogenic pain from endplate degeneration, NOT acute fracture pain. The evidence provided focuses on vertebral augmentation (vertebroplasty/kyphoplasty) for osteoporotic compression fractures 8, 9, 8, which is a completely different indication and procedure than BVNA.
For a patient with persistent axial pain AFTER an osteoporotic vertebral compression fracture has healed, BVNA candidacy would require:
- Fracture healing confirmed on imaging (typically 3+ months post-fracture) 8
- Persistent midline mechanical back pain despite fracture healing
- Development or persistence of Modic changes at the affected or adjacent levels
- Pain pattern consistent with vertebrogenic pain (mechanical, axial, worse with flexion)
- Failure of conservative management including any vertebral augmentation if performed
The case report of BVNA in advanced osteopenia 7 demonstrates safety in metabolic bone disease when no acute fracture is present, suggesting potential applicability in post-fracture scenarios once healing is complete and vertebrogenic pain persists.